Dec 23, 2020
CRISL has assigned “AAA” rating in the Long Term and “ST-1” rating in the Short Term with ‘Stable Outlook’ to Square Pharmaceuticals Ltd with rating validity up to Dec 22, 2021.
CRISL has assigned “AAA” rating in the Long Term and “ST-1” rating in the Short Term with ‘Stable Outlook’ to Square Pharmaceuticals Ltd with rating validity up to Dec 22, 2021.